Listed here are 5 shares added to the Zacks Rank #5 (Sturdy Promote) Record at the moment:
Listed here are 5 shares added to the Zacks Rank #5 (Sturdy Promote) Record at the moment:
Amyris, Inc. AMRS is a biotechnology firm. The Zacks Consensus Estimate for its present 12 months earnings has been revised 29.3% downward during the last 30 days.
ThermoGenesis Holdings, Inc. THMO is a developer and marketer of automated applied sciences for chimeric antigen receptor (CAR)-T and different cell-based therapies. The Zacks Consensus Estimate for its present 12 months earnings has been revised 42.4% downward during the last 30 days.
Cogent Biosciences, Inc. COGT is engaged in growing a pipeline of novel therapies to deal with most cancers sufferers. The Zacks Consensus Estimate for its present 12 months earnings has been revised greater than 100% downward during the last 30 days.
Dolby Laboratories, Inc. DLB is a creator of audio and imaging applied sciences. The Zacks Consensus Estimate for its present 12 months earnings has been revised 1.6% downward during the last 30 days.
HOOKIPA Pharma Inc. HOOK is a scientific stage biopharmaceutical firm. The Zacks Consensus Estimate for its present 12 months earnings has been revised 16.1% downward during the last 30 days.
View your complete Zacks Rank #5 Record.
Need the newest suggestions from Zacks Funding Analysis? At this time, you may obtain 7 Finest Shares for the Subsequent 30 Days. Click on to get this free report
Dolby Laboratories (DLB): Free Inventory Evaluation Report
HOOKIPA Pharma Inc. (HOOK): Free Inventory Evaluation Report
Amyris, Inc. (AMRS): Free Inventory Evaluation Report
Cogent Biosciences, Inc. (COGT): Free Inventory Evaluation Report
Cesca Therapeutics Inc. (THMO): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.